Myriad Genetics | MYGN - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Agilent USD 1.76B 31M 2025-12
Becton, Dickinson and Co. USD 740M 99M 2025-12
Bio-Rad Laboratories USD 529.8M 134M 2025-12
Bruker USD 293.1M 201.1M 2025-09
Danaher USD 4.62B 3.09B 2025-12
Exact Sciences USD 956M 166.96M 2025-12
Hologic USD 2.17B 208.5M 2025-12
Illumina USD 1.42B 368M 2025-12
J&J USD 19.71B 1.48B 2025-12
Mettler Toledo International USD 69.06M 7.24M 2025-09
Myriad Genetics USD 145.4M 71M 2025-09
OraSure Technologies USD 216.48M 18.1M 2025-09
Pacific Biosciences Of California USD 56.47M 1.66M 2025-09
Quest Diagnostics USD 420M 12M 2025-12
Quidel USD 169.8M 71.7M 2025-12
Repligen USD 566.02M 182.73M 2025-12
Revvity USD 919.86M 11.53M 2025-12
Standard Biotools USD 129.42M 29.2M 2025-09
Thermo Fisher Scientific USD 9.85B 7.87B 2025-12
Veracyte USD 362.58M 47M 2025-12
Waters USD 587.83M 128.71M 2025-12